🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Oregano and Basil Leaves and Coronary Artery Disease

RecruitingNAAges 30 Years - 75 YearsAllShahid Beheshti University of Medical Sciences
NCT07123181 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with unstable angina Exclusion Criteria: * Patients diagnosed with STEMI * Patients undergoing coronary artery bypass grafting * Liver cirrhosis and advanced chronic kidney disease (CKD 5) * Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid medications * Pregnancy or breastfeeding
💊

What it tests

  • Control (Standard treatment)
  • Higher polyphenol intake by consumption of oregano and basil
📍

Where

1 site
Imam Husain hospital
Tehran, Iran
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy